Cargando…

Development and Validation of a Nomogram to Predict the 180-Day Readmission Risk for Chronic Heart Failure: A Multicenter Prospective Study

Background: The existing prediction models lack the generalized applicability for chronic heart failure (CHF) readmission. We aimed to develop and validate a widely applicable nomogram for the prediction of 180-day readmission to the patients. Methods: We prospectively enrolled 2,980 consecutive pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Shanshan, Yin, Gang, Xia, Qing, Wu, Guihai, Zhu, Jinxiu, Lu, Nan, Yan, Jingyi, Tan, Xuerui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452908/
https://www.ncbi.nlm.nih.gov/pubmed/34557533
http://dx.doi.org/10.3389/fcvm.2021.731730
_version_ 1784570174181998592
author Gao, Shanshan
Yin, Gang
Xia, Qing
Wu, Guihai
Zhu, Jinxiu
Lu, Nan
Yan, Jingyi
Tan, Xuerui
author_facet Gao, Shanshan
Yin, Gang
Xia, Qing
Wu, Guihai
Zhu, Jinxiu
Lu, Nan
Yan, Jingyi
Tan, Xuerui
author_sort Gao, Shanshan
collection PubMed
description Background: The existing prediction models lack the generalized applicability for chronic heart failure (CHF) readmission. We aimed to develop and validate a widely applicable nomogram for the prediction of 180-day readmission to the patients. Methods: We prospectively enrolled 2,980 consecutive patients with CHF from two hospitals. A nomogram was created to predict 180-day readmission based on the selected variables. The patients were divided into three datasets for development, internal validation, and external validation (mean age: 74.2 ± 14.1, 73.8 ± 14.2, and 71.0 ± 11.7 years, respectively; sex: 50.2, 48.8, and 55.2% male, respectively). At baseline, 102 variables were submitted to the least absolute shrinkage and selection operator (Lasso) regression algorithm for variable selection. The selected variables were processed by the multivariable Cox proportional hazards regression modeling combined with univariate analysis and stepwise regression. The model was evaluated by the concordance index (C-index) and calibration plot. Finally, the nomogram was provided to visualize the results. The improvement in the regression model was calculated by the net reclassification index (NRI) (with tenfold cross-validation and 200 bootstraps). Results: Among the selected 2,980 patients, 1,696 (56.9%) were readmitted within 180 days, and 1,502 (50.4%) were men. A nomogram was established by the results of Lasso regression, univariate analysis, stepwise regression and multivariate Cox regression, as well as variables with clinical significance. The values of the C-index were 0.75 [95% confidence interval (CI): 0.72–0.79], 0.75 [95% CI: 0.69–0.81], and 0.73 [95% CI: 0.64–0.83] for the development, internal validation, and external validation datasets, respectively. Calibration plots were provided for both the internal and external validation sets. Five variables including history of acute heart failure, emergency department visit, age, blood urea nitrogen level, and beta blocker usage were considered in the final prediction model. When adding variables involving hospital discharge way, alcohol taken and left bundle branch block, the calculated values of NRI demonstrated no significant improvements. Conclusions: A nomogram for the prediction of 180-day readmission of patients with CHF was developed and validated based on five variables. The proposed methodology can improve the accurate prediction of patient readmission and have the wide applications for CHF.
format Online
Article
Text
id pubmed-8452908
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84529082021-09-22 Development and Validation of a Nomogram to Predict the 180-Day Readmission Risk for Chronic Heart Failure: A Multicenter Prospective Study Gao, Shanshan Yin, Gang Xia, Qing Wu, Guihai Zhu, Jinxiu Lu, Nan Yan, Jingyi Tan, Xuerui Front Cardiovasc Med Cardiovascular Medicine Background: The existing prediction models lack the generalized applicability for chronic heart failure (CHF) readmission. We aimed to develop and validate a widely applicable nomogram for the prediction of 180-day readmission to the patients. Methods: We prospectively enrolled 2,980 consecutive patients with CHF from two hospitals. A nomogram was created to predict 180-day readmission based on the selected variables. The patients were divided into three datasets for development, internal validation, and external validation (mean age: 74.2 ± 14.1, 73.8 ± 14.2, and 71.0 ± 11.7 years, respectively; sex: 50.2, 48.8, and 55.2% male, respectively). At baseline, 102 variables were submitted to the least absolute shrinkage and selection operator (Lasso) regression algorithm for variable selection. The selected variables were processed by the multivariable Cox proportional hazards regression modeling combined with univariate analysis and stepwise regression. The model was evaluated by the concordance index (C-index) and calibration plot. Finally, the nomogram was provided to visualize the results. The improvement in the regression model was calculated by the net reclassification index (NRI) (with tenfold cross-validation and 200 bootstraps). Results: Among the selected 2,980 patients, 1,696 (56.9%) were readmitted within 180 days, and 1,502 (50.4%) were men. A nomogram was established by the results of Lasso regression, univariate analysis, stepwise regression and multivariate Cox regression, as well as variables with clinical significance. The values of the C-index were 0.75 [95% confidence interval (CI): 0.72–0.79], 0.75 [95% CI: 0.69–0.81], and 0.73 [95% CI: 0.64–0.83] for the development, internal validation, and external validation datasets, respectively. Calibration plots were provided for both the internal and external validation sets. Five variables including history of acute heart failure, emergency department visit, age, blood urea nitrogen level, and beta blocker usage were considered in the final prediction model. When adding variables involving hospital discharge way, alcohol taken and left bundle branch block, the calculated values of NRI demonstrated no significant improvements. Conclusions: A nomogram for the prediction of 180-day readmission of patients with CHF was developed and validated based on five variables. The proposed methodology can improve the accurate prediction of patient readmission and have the wide applications for CHF. Frontiers Media S.A. 2021-09-07 /pmc/articles/PMC8452908/ /pubmed/34557533 http://dx.doi.org/10.3389/fcvm.2021.731730 Text en Copyright © 2021 Gao, Yin, Xia, Wu, Zhu, Lu, Yan and Tan. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Gao, Shanshan
Yin, Gang
Xia, Qing
Wu, Guihai
Zhu, Jinxiu
Lu, Nan
Yan, Jingyi
Tan, Xuerui
Development and Validation of a Nomogram to Predict the 180-Day Readmission Risk for Chronic Heart Failure: A Multicenter Prospective Study
title Development and Validation of a Nomogram to Predict the 180-Day Readmission Risk for Chronic Heart Failure: A Multicenter Prospective Study
title_full Development and Validation of a Nomogram to Predict the 180-Day Readmission Risk for Chronic Heart Failure: A Multicenter Prospective Study
title_fullStr Development and Validation of a Nomogram to Predict the 180-Day Readmission Risk for Chronic Heart Failure: A Multicenter Prospective Study
title_full_unstemmed Development and Validation of a Nomogram to Predict the 180-Day Readmission Risk for Chronic Heart Failure: A Multicenter Prospective Study
title_short Development and Validation of a Nomogram to Predict the 180-Day Readmission Risk for Chronic Heart Failure: A Multicenter Prospective Study
title_sort development and validation of a nomogram to predict the 180-day readmission risk for chronic heart failure: a multicenter prospective study
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452908/
https://www.ncbi.nlm.nih.gov/pubmed/34557533
http://dx.doi.org/10.3389/fcvm.2021.731730
work_keys_str_mv AT gaoshanshan developmentandvalidationofanomogramtopredictthe180dayreadmissionriskforchronicheartfailureamulticenterprospectivestudy
AT yingang developmentandvalidationofanomogramtopredictthe180dayreadmissionriskforchronicheartfailureamulticenterprospectivestudy
AT xiaqing developmentandvalidationofanomogramtopredictthe180dayreadmissionriskforchronicheartfailureamulticenterprospectivestudy
AT wuguihai developmentandvalidationofanomogramtopredictthe180dayreadmissionriskforchronicheartfailureamulticenterprospectivestudy
AT zhujinxiu developmentandvalidationofanomogramtopredictthe180dayreadmissionriskforchronicheartfailureamulticenterprospectivestudy
AT lunan developmentandvalidationofanomogramtopredictthe180dayreadmissionriskforchronicheartfailureamulticenterprospectivestudy
AT yanjingyi developmentandvalidationofanomogramtopredictthe180dayreadmissionriskforchronicheartfailureamulticenterprospectivestudy
AT tanxuerui developmentandvalidationofanomogramtopredictthe180dayreadmissionriskforchronicheartfailureamulticenterprospectivestudy